Soleno Therapeutics Inc financial data

Symbol
SLNO on Nasdaq
Location
100 Marine Parkway, Suite 400, Redwood City, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.64K % -5.1%
Debt-to-equity 30.4 % +148%
Return On Equity -25.9 % +58.3%
Return On Assets -19.8 % +64.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.7M shares +24.6%
Common Stock, Shares, Outstanding 53.7M shares +30.9%
Entity Public Float 1.4B USD +4130%
Common Stock, Value, Issued 54K USD +31.7%
Weighted Average Number of Shares Outstanding, Basic 53.3M shares +27.3%
Weighted Average Number of Shares Outstanding, Diluted 54.9M shares +31.1%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 1.14M USD
Research and Development Expense 52.6M USD -20.1%
General and Administrative Expense 106M USD +685%
Costs and Expenses 43.9M USD -45.3%
Operating Income (Loss) -89.3M USD +37.3%
Nonoperating Income (Expense) 10.8M USD -4.18%
Net Income (Loss) Attributable to Parent -78.5M USD +40.2%
Earnings Per Share, Basic -1 USD/shares +28.4%
Earnings Per Share, Diluted -1 USD/shares +27.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 247M USD +409%
Marketable Securities, Current 252M USD +21.1%
Accounts Receivable, after Allowance for Credit Loss, Current 25.5M USD
Inventory, Net 6.67M USD
Assets, Current 535M USD +107%
Property, Plant and Equipment, Net 150K USD -23.5%
Operating Lease, Right-of-Use Asset 2.31M USD -22.7%
Intangible Assets, Net (Excluding Goodwill) 5.35M USD -26.7%
Other Assets, Noncurrent 83K USD 0%
Assets 600M USD +102%
Accounts Payable, Current 8.15M USD +30.5%
Employee-related Liabilities, Current 7.25M USD +113%
Liabilities, Current 33.3M USD +122%
Operating Lease, Liability, Noncurrent 2.11M USD -18.2%
Other Liabilities, Noncurrent 398K USD
Liabilities 105M USD +228%
Accumulated Other Comprehensive Income (Loss), Net of Tax 360K USD -59.8%
Retained Earnings (Accumulated Deficit) -475M USD -19.8%
Stockholders' Equity Attributable to Parent 495M USD +86.9%
Liabilities and Equity 600M USD +102%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32.8M USD -161%
Net Cash Provided by (Used in) Financing Activities 3.22M USD +243%
Net Cash Provided by (Used in) Investing Activities 22.9K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 53.7M shares +30.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.6M USD +94.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 247M USD +409%
Interest Paid, Excluding Capitalized Interest, Operating Activities 805K USD
Deferred Tax Assets, Valuation Allowance 83.5M USD +26.6%
Deferred Tax Assets, Gross 85.5M USD +26%
Operating Lease, Liability 2.81M USD -7.26%
Payments to Acquire Property, Plant, and Equipment 5K USD -54.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -79M USD +39.4%
Lessee, Operating Lease, Liability, to be Paid 3.34M USD -12.4%
Property, Plant and Equipment, Gross 256K USD +153%
Operating Lease, Liability, Current 697K USD +55.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 861K USD +14.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 751K USD +42.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 528K USD -32.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 942K USD +9.41%
Deferred Tax Assets, Operating Loss Carryforwards 44.3M USD -13.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 6.37M USD +117%
Lessee, Operating Lease, Liability, to be Paid, Year Four 665K USD -29.4%
Operating Lease, Payments 103K USD +60.9%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 83.5M USD +26.6%
Share-based Payment Arrangement, Expense 64.1M USD -11.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%